News room

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment

Save the Date: Egetis to host a Capital Markets Day in Stockholm on October 13, 2022

August 18, 2022

Stockholm, Sweden, August 18, 2022. Egetis Therapeutics AB (publ) (Nasdaq Stockholm: EGTX) today announced that the Company will host a Capital Markets Day on Thursday, October 13, 2022, in Stockholm, Sweden, for investors, analysts and media.
Time: Thursday, October 13, 2022, at 1:00 pm – 5:00 pm CEST
Venue: Erik Penser Bank, Apelbergsgatan 27, Stockholm, Sweden
The event will also be accessible through a live webcast.
During the event, the Company will provide an update and review of its strategy and pipeline. The presentations will focus on the unmet medical need, development plans, commercial opportunities, and additional activities to create and enhance long-term shareholder value.  Presentations will be made by members of Egetis’ management team and Board, as well as invited key opinion leaders.
A complete agenda and a link to the live webcast will be shared in advance of the event.
Presentations will be held in English.
To attend in person in Stockholm, please sign up here 



Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10